TECregen - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTECregen
TECregen logo

TECregen

0 followers

About TECregen

TECregen is a Swiss biotechnology company focused on regenerative immunology, engineering thymopoietics to regenerate the thymus and restore immune balance. The company develops first-in-class therapies aimed at immune decline, cancer, and inflammatory diseases, with research and development activities centered in Switzerland. TECregen integrates advanced ligand engineering, targeted delivery, and functional screening to drive thymus regeneration and long-lasting immune restoration. The organization positions itself as a leader in a new class of regenerative biologics.

Recent News

Recent Deals

Key Team Members

Abinand Rangesh

Chief Executive Officer and Director

Robert A. Panora

Chief Operations Officer and President

Roger Deschenes

Chief Financial Officer, Chief Accounting Officer and Treasurer

Stephen Lafaille

Vice President of Business Development

Key Facts

HQ Location

Basel, Switzerland

Employees

1 - 10

Status

Private

Website

https://tecregen.com